Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

1. 01

   How might covering multi-cancer screening tests affect Medicare's total spending, and what evidence supports that this early detection reduces overall cancer treatment costs?

2. 02

   Who would benefit most from access to these screening tests, and could the age-based eligibility create disparities among older Medicare beneficiaries?

3. 03

   What criteria should CMS use to decide which multi-cancer tests qualify for coverage, and how might this bill's approval timeline align with FDA's drug review process?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.